About Us
VirtualScopics is a leading imaging core lab providing central reads and quantitative imaging solutions for drug and medical device clinical trials. We provide an unparalleled depth of experience, technological capability and expertise in medical imaging. Our services support all aspects of imaging in clinical trials, from design to FDA submission, pre-clinical through Phase IV. We are a company with a commitment to customer service that strives to surpass what our customers expect. We respond quickly, foresee challenges sooner, and get you the answers you need faster—all in a manner that gives you a deep sense of trust and confidence.
As a leader in image analysis, VirtualScopics utilizes its patented suite of algorithms to detect, measure and analyze specific biological structures from medical image data, such as those provided by computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. VirtualScopics' technology enables faster and more reliable detection of disease progression or therapeutic benefit, which can then accelerate the clinical trial process.
Therapeutic area expertise includes: oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements, and COPD studies utilizing MRI, PET, CT, Ultrasound, and X-Ray imaging modalities. Advanced semi-automated analysis software is used in conjunction with expert technicians and radiologists to quantify image-based biomarkers to deliver precise and repeatable measurements. This delivers the opportunity for compressed trial time, reduced subject sample size, real-time reads and the ability to prove drug or device efficacy earlier. Most importantly, we can help sponsors get the right drugs to market faster and ultimately save lives.